ACM
WGS icon

ACT Capital Management’s GeneDx Holdings WGS Stock Holding History

ACT Capital Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$275K Sell
4,000
-4,000
-50% -$227K 0.18% 54
2026
Q1 		$514K Buy
8,000
+5,000
+167% +$456K 0.4% 31
2025
Q4 		$390K Buy
+3,000
New +$412K 0.32% 36

Other funds holding WGS

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
LAI
Legal Advantage Investments Los Altos Hills, California $285M AUM 18.63% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
SC
Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
GC
Grange Capital Beaverton, Oregon $108M AUM 18.7% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

ACT Capital Management's WGS Position: Q2 2026 in Review

ACT Capital Management reduced its GeneDx Holdings (WGS) stake by 50% in Q2 2026, selling an estimated $227K and leaving 4,000 shares worth $275K. The position accounts for 0.18% of the portfolio, ranked #54.

ACT Capital Management first reported a position in WGS in Q4 2025 and has held it in 3 quarters since. The position peaked at $514K in Q1 2026. 39 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • ACT Capital Management held 4,000 shares of GeneDx Holdings worth $275K as of Q2 2026.
  • ACT Capital Management sold 4,000 GeneDx Holdings shares in Q2 2026, an estimated $227K.
  • GeneDx Holdings made up 0.18% of ACT Capital Management's portfolio in Q2 2026, its #54 holding.
  • ACT Capital Management first reported a position in GeneDx Holdings in Q4 2025 and has held it in 3 quarters since.
  • ACT Capital Management's GeneDx Holdings position peaked at $514K in Q1 2026.
  • 39 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on ACT Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.